275 related articles for article (PubMed ID: 16399422)
1. Multimodality therapy of local regional esophageal cancer.
Kelsen DP
Semin Oncol; 2005 Dec; 32(6 Suppl 9):S6-10. PubMed ID: 16399422
[TBL] [Abstract][Full Text] [Related]
2. Cancer of the gastroesophageal junction: combined modality therapy.
Ilson DH
Surg Oncol Clin N Am; 2006 Oct; 15(4):803-24. PubMed ID: 17030275
[TBL] [Abstract][Full Text] [Related]
3. Esophageal cancer: adjuvant therapy.
Ku GY; Ilson DH
Cancer J; 2007; 13(3):162-7. PubMed ID: 17620765
[TBL] [Abstract][Full Text] [Related]
4. Preoperative and adjuvant therapies for upper gastrointestinal cancers.
Varadhachary G; Ajani JA
Expert Rev Anticancer Ther; 2005 Aug; 5(4):719-25. PubMed ID: 16111471
[TBL] [Abstract][Full Text] [Related]
5. Palliative therapy.
Homs MY; Kuipers EJ; Siersema PD
J Surg Oncol; 2005 Dec; 92(3):246-56. PubMed ID: 16299791
[TBL] [Abstract][Full Text] [Related]
6. A phase II trial of accelerated multimodality therapy for locoregionally advanced cancer of the esophagus and gastroesophageal junction: the impact of clinical heterogeneity.
Adelstein DJ; Rice TW; Rybicki LA; Saxton JP; Videtic GM; Murthy SC; Zuccaro G; Vargo JJ; Dumot JA; Carroll MA
Am J Clin Oncol; 2007 Apr; 30(2):172-80. PubMed ID: 17414467
[TBL] [Abstract][Full Text] [Related]
7. Preoperative therapy in esophageal cancer.
Ku GY; Ilson DH
Clin Adv Hematol Oncol; 2008 May; 6(5):371-9. PubMed ID: 18516027
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant and adjuvant chemotherapy for esophageal adenocarcinoma.
Mooney MM
J Surg Oncol; 2005 Dec; 92(3):230-8. PubMed ID: 16299790
[TBL] [Abstract][Full Text] [Related]
9. Multimodality therapy for the curative treatment of cancer of the esophagus and gastroesophageal junction.
Ku GY; Ilson DH
Expert Rev Anticancer Ther; 2008 Dec; 8(12):1953-64. PubMed ID: 19046115
[TBL] [Abstract][Full Text] [Related]
10. Perioperative chemo(radio)therapy versus primary surgery for resectable adenocarcinoma of the stomach, gastroesophageal junction, and lower esophagus.
Ronellenfitsch U; Schwarzbach M; Hofheinz R; Kienle P; Kieser M; Slanger TE; Jensen K;
Cochrane Database Syst Rev; 2013 May; (5):CD008107. PubMed ID: 23728671
[TBL] [Abstract][Full Text] [Related]
11. Phase II study of preoperative paclitaxel/cisplatin with radiotherapy in locally advanced esophageal cancer.
Kim DW; Blanke CD; Wu H; Shyr Y; Berlin J; Beauchamp RD; Chakravarthy B
Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):397-404. PubMed ID: 17097833
[TBL] [Abstract][Full Text] [Related]
12. Radiation and chemoradiation therapy for esophageal adenocarcinoma.
Bosset JF; Lorchel F; Mantion G; Buffet J; Créhange G; Bosset M; Chaigneau L; Servagi S
J Surg Oncol; 2005 Dec; 92(3):239-45. PubMed ID: 16299784
[TBL] [Abstract][Full Text] [Related]
13. Role of neoadjuvant therapy for esophageal adenocarcinoma.
Ku GY; Ilson DH
Surg Oncol Clin N Am; 2009 Jul; 18(3):533-46. PubMed ID: 19500742
[TBL] [Abstract][Full Text] [Related]
14. Expert opinion on management of gastric and gastro-oesophageal junction adenocarcinoma on behalf of the European Organisation for Research and Treatment of Cancer (EORTC)-gastrointestinal cancer group.
Van Cutsem E; Van de Velde C; Roth A; Lordick F; Köhne CH; Cascinu S; Aapro M;
Eur J Cancer; 2008 Jan; 44(2):182-94. PubMed ID: 18093827
[TBL] [Abstract][Full Text] [Related]
15. Clinical aspects of multimodality therapy for resectable locoregional esophageal cancer.
Shinoda M; Hatooka S; Mori S; Mitsudomi T
Ann Thorac Cardiovasc Surg; 2006 Aug; 12(4):234-41. PubMed ID: 16977291
[TBL] [Abstract][Full Text] [Related]
16. The impact of multimodality therapy of distal esophageal and gastroesophageal junction adenocarcinomas on treatment-related toxicity and complications.
Monjazeb AM; Blackstock AW
Semin Radiat Oncol; 2013 Jan; 23(1):60-73. PubMed ID: 23207048
[TBL] [Abstract][Full Text] [Related]
17. Is multimodality therapy an option to surgery alone in adenocarcinoma of the gastroesophageal junction?
Temple WJ
Can J Surg; 1990 Apr; 33(2):85-6. PubMed ID: 2268816
[No Abstract] [Full Text] [Related]
18. [Oesophageal cancer: current status of multimodality therapy].
Vallböhmer D; Schröder W; Brabender J; Hölscher AH
Zentralbl Chir; 2011 Aug; 136(4):312-6. PubMed ID: 21863509
[TBL] [Abstract][Full Text] [Related]
19. Therapy for locally advanced adenocarcinoma of the gastroesophageal junction: optimizing outcome.
Kleinberg L
Semin Radiat Oncol; 2013 Jan; 23(1):38-50. PubMed ID: 23207046
[TBL] [Abstract][Full Text] [Related]
20. Morbidity and mortality are not increased after induction chemoradiotherapy followed by esophagectomy in patients with esophageal cancer.
Berger AC; Scott WJ; Freedman G; Konski A; Weiner L; Cheng JD; Goldberg M
Semin Oncol; 2005 Dec; 32(6 Suppl 9):S16-20. PubMed ID: 16399424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
